What the thing is
Artificial scarcity is the deliberate restriction of availability for non-rivalrous or easily reproducible goods—even when production or sharing capacity is sufficient.
Goods and ideas differ: two people who swap apples each still have one, but two people who swap ideas each end up with two. Ideas are nonetheless often treated as scarce inventions or creative works and protected as intellectual property, so that their authors can potentially profit.
Where it came from
It emerged from economic analysis of deadweight loss in capitalist and mixed economies, where firms restrict output to raise prices and sustain profits.
Profit is the frame: a capitalist enterprise is judged successful if it is profitable, so producers may restrict production rather than maximise the use of resources. Where competition is robust, price tends toward marginal cost plus enough profit to make entering the market worthwhile. Where it is insufficient, suppliers can use market power to constrict supply. A monopoly is the clearest case, and an oligopoly can sustain undersupply too if no producer tries to gain market share with lower prices.
What it gets right
It correctly identifies that scarcity is manufactured—not inevitable—where technology and capacity exist but are deliberately underused. It names monopoly pricing, weak competition, and legal instruments as concrete levers, not vague forces.
Competition fails in several ways: cartels, barriers to entry (some inherent, such as the cost of building a factory, some created by regulation or by incumbents), monopolies created in law to encourage innovation, copyright used to disallow copying or access, and patents. It adds that governments create scarcity themselves through price supports, citing the 1933 Agricultural Adjustment Act in the United States, the destruction of coffee by the Brazil National Coffee Council, and the butter mountains left by European Union guaranteed purchases.
What it gets wrong
It treats all opposition to artificial scarcity as ideological (libertarian, socialist, anarchist), ignoring that practical objections arise from engineers, educators, and public health workers—not just theorists.
It also leaves out the case made for it. Advocates hold that artificial scarcity is needed to promote the development of goods: copying information may be cheap but producing it first can take significant investment, and most drugs are inexpensive to make at scale yet extremely expensive to develop. It notes that drug companies typically earn margins well beyond what repaying their investment requires, and that it is argued the high payoff attracts investment and labour talent.
Why it matters now
Because digital infrastructure enables near-zero-cost replication and distribution—and yet copyright terms lengthen, patents broaden, and platforms gatekeep data, widening the gap between capacity and access.
The digital case has two sides. Producers enforce payment by copy protection, digital rights management, paywalls and cease-and-desist letters, while copyleft advocates use copyright licences to guarantee the right to copy, access, view and change source code.
Is it worth your time
Yes—if you care how profit reshapes access to ideas, information, and infrastructure. It is not abstract theory. It is the logic behind paywalled research, DRM-locked software, and patent-blocked medicines.
